Related Experiment Videos
Squamous-cell carcinoma of the anus
Acta Chirurgica Scandinavica
|January 1, 1975
Summary
Squamous-cell carcinoma of the anus has a high recurrence rate. Curative treatments like abdominoperineal resection and local excision offer promising survival rates for anal cancer patients.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Squamous-cell carcinoma of the anus is a rare malignancy.
- Treatment outcomes for anal cancer vary significantly.
- Prognosis is influenced by tumor location and treatment modality.
Purpose of the Study:
- To evaluate the treatment outcomes for patients with squamous-cell carcinoma of the anus.
- To analyze the impact of treatment type and tumor location on prognosis.
- To assess survival rates following different surgical interventions.
Main Methods:
- Retrospective study of 29 patients treated for squamous-cell carcinoma of the anus.
- Analysis of treatment modalities including palliative care, abdominoperineal resection, and local excision.
- Follow-up data on recurrence-free survival and overall survival.
Main Results:
- 52% of patients died from recurrent disease within 3 years.
- Among 24 patients treated curatively, 19 underwent abdominoperineal resection with 10 surviving disease-free for 3-11 years.
- Local excision in 5 patients resulted in 4 being alive without recurrence at 3-6 years.
Conclusions:
- Squamous-cell carcinoma of the anus carries a significant risk of recurrence.
- Abdominoperineal resection and local excision demonstrate potential for long-term disease-free survival.
- Tumor location and choice of curative treatment are critical factors in anal cancer prognosis.